Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Biovian
Biovian
Activities:
Manufacturing
X
LinkedIn
Trending Articles
Rentschler Biopharma appoints Patrick Cushing as VP Operations for US subsidiary
The novel position will require Dr Cushing to manager operations at the Miford, MA facility in the US
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Johnson & Johnson submits regulatory application for Tremfya to the European Medicines Agency
The submission included data from the Phase 3 QUASAR programme in ulcerative colitis and the Phase 3 GALAXI programme in Crohn’s disease, which each achieved their primary...
Amolyt receives FDA fast track designation for hypoparathyroidism drug
The therapeutic has been awarded the fast track designation owing to the Phase III Calypso trial, which showed promising efficacy and safety features
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Media
Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN
Biovian and 3P Biopharmaceuticals, two leading biologics CDMOs, announce their combination to establish a new pan-European leader in their field
Manufacturing
Biovian announces over €50 million investment in Finnish viral vector facility
The additional space complements Biovian’s existing manufacturing facilities in the area and will enable Biovian to undertake larger-scale viral vector as well as microbial protein projects
Manufacturing
Lokon and Biovian sign manufacturing agreement for cancer therapy
The agreement covers the development and manufacturing of the viral vector LOAd703 at Biovian’s facility in Turku, Finland
Manufacturing
Tenboron and Biovian sign manufacturing agreement for cancer therapy
The agreement covers technical transfer, analytical method validation and GMP manufacturing of boron carriers at Biovian’s facility in Turku, Finland
Biovian appoints Head of Global Business Development
Dr Magnus Gustafsson has been chosend to runt he business and marketing team
Subscribe now